Recent Comments
- admin on A Surgeon’s Story: Decision-making
- Margaret McGregor on A Surgeon’s Story: Decision-making
- LB on Has Bobby Kennedy’s campaign been infiltrated by intelligence operations?
- IwasHere on Pfizer admits in federal court that the COVID gene therapies were never approved through the FDA
- Anonymous on Pfizer admits in federal court that the COVID gene therapies were never approved through the FDA
Most Viewed Posts
- Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market (16,625)
- Pfizer admits in federal court that the COVID gene therapies were never approved through the FDA (15,166)
- Gordon Guyatt, MD: Update on the problem of clinical trials being stopped early to inflate efficacy of drugs (14,642)
- New treatment paradigm for C. Diff colitis (14,555)
- I discuss the handling of the COVID-19 outbreak on The Joe Piscopo radio show (14,076)
- How the FDA regulates compounding pharmacies (13,862)
- The Healthcare Channel hits 10 (13,158)
- The new CDC guidelines for prescribing opioid pain pills (8,828)
- The Who’s Teen Cancer Lounge at Sloan Kettering opens (8,276)
- Exclusive: Michael Bloomberg took control of Johns Hopkins with his billions. Then, death rates skyrocketed at a children’s hospital. (8,051)
Pages
Categories
- – Biotech
- – Generics
- – JAMA
- – Medical Devices
- – NEJM
- – Opinion
- – Pharma
- – Policy
- – Reviews, books, devices
- – The Weekly Summary
- Bariatric surgery
- Cardiac surgery
- Cardiology
- Dermatology
- Diabetes and endocrinology
- Emergency medicine
- Gastroenterology and liver
- General surgery
- Genetics
- Geriatrics
- Infectious disease
- Internal Medicine
- Neurology
- Neurosurgery
- Obstetrics and Gynecology
- Oncology
- Ophthalmology
- Orthopedic surgery
- Pediatrics
- Plastic surgery
- Primary care medicine
- Psychology Psychiatry
- Pulmonology
- Radiology
- Rheumatology
- Spine surgery
- Sports medicine
- Transplant surgery
- Trauma Surgery
- Uncategorized
- Urology
- Vascular Surgery
- Z Medical centers
- Baylor
- Boston University
- Cedars Sinai
- Cleveland Clinic
- Columbia
- Cornell
- Duke
- Emory
- George Washington Univ
- Harvard
- Henry Ford
- Iowa State
- Johns Hopkins
- Mayo Clinic
- McMaster University
- Medical University of South Carolina
- Memorial Sloan-Kettering
- Michigan
- National Jewish Health
- NYU
- Ohio State
- Oregon Health and Science University
- UC Davis
- UC San Francisco
- UCLA
- Univ Kentucky
- Univ Maryland
- Univ Miami
- Univ Michigan
- Univ of Louisville
- Univ Texas
- VA Walter Reed
- Vanderbilt
- VCU
- Washington University
- Yale
Category Archives: Infectious disease
Greer v. The Lancet 4:23-cv-03761 S.D.T.X.
October 1, 2023- by Steven E. Greer, MD
Posted in - Opinion, CDC, CMS, Congress, FDA, Infectious disease, NIH, Pulmonology
Leave a comment
mRNA vaccine boosters and impaired immune system response
February 3, 2024- by Steven E. Greer, MD
Posted in - Biotech, - Opinion, CDC, Congress, FDA, Infectious disease
Leave a comment
Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market
The transcript is found here May 19, 2023- by Steven E. Greer, MD
Interview with Hélène Banoun about why mRNA “vaccines” should be regulated as gene therapies
July 12, 2023- by Steven E. Greer, MD
Posted in - Biotech, - Opinion, - Pharma, - Policy, Cardiology, CDC, Congress, FDA, Infectious disease, Internal Medicine, Oncology
Leave a comment
Interview with Leslie Manookian, founder of Health Freedom Defense legal fund fighting mask and vaccine mandates
October 6, 2023- by Steven E. Greer, MD
Pfizer admits in federal court that the COVID gene therapies were never approved through the FDA
January 19, 2024- by Steven E. Greer, MD
Posted in - Opinion, - Pharma, CDC, Congress, FDA, Infectious disease
5 Comments
Interview with drug trials expert Sasha Latypova on how the COVID vaccine approvals were a sham
July 7, 2023- by Steven E. Greer, MD
Posted in - Biotech, - Opinion, - Pharma, - Policy, CDC, FDA, Infectious disease, NIH
Leave a comment
Paxlovid causes rebound COVID 25% of the time
January 7, 2024- by Steven E. Greer, MD
Posted in - Pharma, CDC, Emergency medicine, Infectious disease
Leave a comment
Book: The Pfizer/Moderna mRNA Vaccine (i.e., gene therapy) Toxicity
September 1, 2023- by Sucharit Bhakdi, MD et al
Ivermectin works as an antiviral against SARS-CoV-2 (COVID-19)
Update September 4, 2022- A new peer-reviewed study found that regular use of ivermectin reduced the risk of dying from COVID-19 by 92%.
Posted in - Biotech, - Generics, - Pharma, FDA, Infectious disease
Leave a comment
Ivermectin works against COVID in double blind, randomized, controlled trial
May 2, 2023- by Steven E. Greer, MD A new medical meeting poster shows the results of a double blind, randomized, controlled trial of ivermectin as a therapy for COVID. The drug works very well.
Steven E. Greer, MD on OANN discussing virus therapies
April 16, 2020
Did the COVID vaccines change the human genome?
May 11, 2023- by Steven E. Greer, MD I was the first person on any large media platform to warn that the COVID vaccines would be hard to sell because they worked by altering our genes. I said this on … Continue reading
Posted in - Biotech, - Opinion, - Pharma, - Policy, Cardiology, CDC, FDA, Infectious disease, Internal Medicine, Neurology, NIH, Oncology
Leave a comment
Rudy Giuliani interviews Steven E. Greer, MD on WABC radio- May 6, 2020
May 6, 2020
Posted in - Opinion, - Policy, CDC, CMS, Congress, Emergency medicine, FDA, Infectious disease, NIH
Leave a comment
WABC radio morning show Bernie & Sid interviews Steven E. Greer, MD: May 21, 2020
May 21, 2020- by Steven E. Greer, MD In this segment,
Tony’s Virus
October 15, 2020- by Steven E. Greer, MD
I discuss the handling of the COVID-19 outbreak on The Joe Piscopo radio show
March 23, 2020- I updated Joe Piscopo today, focusing on the new drugs to treat coronavirus.
Posted in - Opinion, - Policy, CDC, Congress, Emergency medicine, Infectious disease, NIH
Leave a comment
New treatment paradigm for C. Diff colitis
March 31, 2010- Produced and interviewed by Steven E. Greer, MD New drugs